國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Targeting oral cancer

M. Fribley, Andrew.

Targeting oral cancer

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Targeting oral canceredited by Andrew M. Fribley.
其他作者:	M. Fribley, Andrew.
出版者:	Cham :Springer International Publishing :2016.
面頁冊數:	x, 302 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	MouthCancer.
電子資源:	http://dx.doi.org/10.1007/978-3-319-27647-2
ISBN:	9783319276472$q(electronic bk.)

Targeting oral cancer
Targeting oral cancer[electronic resource] /edited by Andrew M. Fribley. - Cham :Springer International Publishing :2016. - x, 302 p. :ill., digital ;24 cm.

Epidemiology and Management: Epidemiology -- Emerging Role of HPV -- Management of Oral Cancer. Development and Biomarkers: Molecular Progression and Signaling -- Stem Cells and Tumor Development -- Prognostic/Predictive Biomarkers -- EIF4e as Biomarker and Target. Breaking Developments and New Drug Discovery: Current Clinical Trials -- Emerging Drug Targets -- Targeting the UPR -- Targeting Meditators of Coagulation -- Resveratrol Pre-Sensitizing -- Academic High Throughput Drug Discovery.

This book provides research-oriented care providers with up-to-date information on the oral cancer patient population, the ways in which we are treating them, and the scientific approaches being pursued in order to improve survival and reduce treatment-related morbidity. The text is organized into three sections covering epidemiology and management, cancer development and biomarkers, and breaking developments and novel approaches for drug discovery. The first section includes discussion of the emerging role of human papillomavirus in oral cancer and explains the surgical, chemotherapy, and radiation approaches to treatment. Aspects such as molecular progression and signaling, the role of cancer stem cells in tumor development, and the value of various biomarkers are then examined. The final section is devoted to the latest advances and covers, among other topics, current clinical trials, emerging drug targets, and targeting of the unfolded protein response and of mediators of coagulation. Recent decades have witnessed a significant increase in the number of deaths worldwide from cancers of the oral cavity, pharynx, and oropharynx. Targeting Oral Cancer will be an excellent resource for practitioners and researchers and will hopefully assist in the urgent quest to improve screening and prevention, diagnosis, and treatment approaches.

ISBN: 9783319276472$q(electronic bk.)

Standard No.: 10.1007/978-3-319-27647-2doiSubjects--Topical Terms:

455488
Mouth
--Cancer.

LC Class. No.: RC280.M6

Dewey Class. No.: 616.99431

Targeting oral cancer
LDR:02745nmm a2200313 a 4500 001 483506
003 DE-He213
005 20160819164941.0
006 m d
007 cr nn 008maaau
008 161007s2016 gw s 0 eng d
020 $a 9783319276472$q(electronic bk.)
020 $a 9783319276458$q(paper)
024 7 $a 10.1007/978-3-319-27647-2 $2 doi
035 $a 978-3-319-27647-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.M6
072 7 $a MMD $2 bicssc
072 7 $a MED016000 $2 bisacsh
082 0 4 $a 616.99431 $2 23
090 $a RC280.M6 $b T185 2016
245 0 0 $a Targeting oral cancer $h [electronic resource] / $c edited by Andrew M. Fribley.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a x, 302 p. : $b ill., digital ; $c 24 cm.
505 0 $a Epidemiology and Management: Epidemiology -- Emerging Role of HPV -- Management of Oral Cancer. Development and Biomarkers: Molecular Progression and Signaling -- Stem Cells and Tumor Development -- Prognostic/Predictive Biomarkers -- EIF4e as Biomarker and Target. Breaking Developments and New Drug Discovery: Current Clinical Trials -- Emerging Drug Targets -- Targeting the UPR -- Targeting Meditators of Coagulation -- Resveratrol Pre-Sensitizing -- Academic High Throughput Drug Discovery.
520 $a This book provides research-oriented care providers with up-to-date information on the oral cancer patient population, the ways in which we are treating them, and the scientific approaches being pursued in order to improve survival and reduce treatment-related morbidity. The text is organized into three sections covering epidemiology and management, cancer development and biomarkers, and breaking developments and novel approaches for drug discovery. The first section includes discussion of the emerging role of human papillomavirus in oral cancer and explains the surgical, chemotherapy, and radiation approaches to treatment. Aspects such as molecular progression and signaling, the role of cancer stem cells in tumor development, and the value of various biomarkers are then examined. The final section is devoted to the latest advances and covers, among other topics, current clinical trials, emerging drug targets, and targeting of the unfolded protein response and of mediators of coagulation. Recent decades have witnessed a significant increase in the number of deaths worldwide from cancers of the oral cavity, pharynx, and oropharynx. Targeting Oral Cancer will be an excellent resource for practitioners and researchers and will hopefully assist in the urgent quest to improve screening and prevention, diagnosis, and treatment approaches.
650 0 $a Mouth $x Cancer. $3 455488
650 0 $a Mouth $x Cancer $x Diagnosis. $3 714511
650 0 $a Mouth $x Cancer $x Treatment. $3 455489
650 1 4 $a Dentistry. $3 276712
650 2 4 $a Oncology. $3 195181
650 2 4 $a Oral and Maxillofacial Surgery. $3 274150
700 1 $a M. Fribley, Andrew. $3 741085
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-27647-2
950 $a Medicine (Springer-11650)